1. Pragmatic and Contextualized Methods Selection for Safety Assessment of Infant Systemic Exposure Through Human Milk: The Milk4baby Decision Tree
3. The use of risk medication during pregnancy: data from the Dutch Pregnancy Drug Register
4. Intravitreal Aflibercept Exposure During Early Pregnancy: Analysis of two cases
6. Evaluation of exposures of glucagon-like peptide-1 receptor agonists during pregnancy: Case series from a university’s teratology information service
7. Sibling and non-sibling designs in studies investigating the risk of drug exposure during pregnancy: same results? A preliminary meta-epidemiological study
8. First trimester exposure to piracetam: A report of four cases
9. Hypersensitivity reactions to parenteral iron in pregnant women and fetal consequences
10. Retrospective study on drug exposure during pregnancy and associated neonatal outcomes in mothers with cardiac diseases
11. High Dose Estrogen During Breastfeeding – A Prospective Study
12. Cognitive development in children exposed to maternal treatment with selective serotonin reuptake inhibitors during pregnancy and breastfeeding
13. Evaluation of prenatal exposures in congenital heart defects in Rio Grande do Sul, Brazil
14. ADHD During Pregnancy and the First Postpartum Year– A Survey Among Norwegian Women
15. High-dose Vitamin D Eggs in Norway: Coordinated Response and Guidance for Pregnant and Breastfeeding Women
16. Associations Between Maternal Prepregnancy Body Mass Index and Maternal and Cord Blood Metabolome
17. Lisdexamfetamine use during lactation - Clinical follow-up of 17 exposed infants
18. Understanding Real-World Concerns and Information Needs on Medication Use During Pregnancy and Lactation in Japan: A Web-Based Survey to Support Future Evidence Generation
19. Lyell syndrome in pregnancy: A case report
20. New Frontiers in Clinical Toxicology. The connection through toxicology and teratology
21. Ocrelizumab use before pregnancy and neonatal B-cell depletion. A case report
22. The Use of Newly Marketed Drugs During Pregnancy and Lactation: The FARVIGRAL Project
23. Benzodiazepines exposure during pregnancy: systematic review and meta-analysis of observational studies
24. A multidisciplinary Consultation Meeting for the Management of Pregnant or Pregnancy-Planning Epileptic Patients
25. Acceptance, comprehensibility and impact of embryotox.de in routine healthcare
27. Association between in utero exposure to acetaminophen and external genital tract malformations in boys and girls: a systematic review and meta-analysis
28. The information system FREIA, a unique work tool to optimize fetal drug safety during pregnancy
29. An exploratory linkage and disproportionality analysis of national congenital anomaly and primary care dispensing data in the UK
30. Exposure to monoclonal antibodies during pregnancy and lactation – a growing concern.
31. Leflunomide exposure in pregnancy: always some uncertainty, a case report that raises questions
32. Descriptive Analysis of Folate Supplementation Patterns and RBC Folate Levels in Women of Reproductive Age in a Brazilian Hospital
33. Asthma medication use before and during pregnancy: guidelines versus multinational practice
34. Maternal high therapeutic dose of iodide during breastfeeding: results from the UmbrelLACT study – A contribution from the ConcePTION project
35. Tacrolimus exposure in human milk: case series from the UmbrelLACT study – A contribution from the ConcePTION project
36. High Dose Estrogen During Breastfeeding – A Prospective Study
37. Rupatadine during breastfeeding: Two case reports
38. A Case Report: Niclosamide and albendazole use during the first trimester of pregnancy
39. Pregnancy outcome following exposure to ergotamine tartrate combinations exposure: Preliminary results of 26 cases
40. Alcohol, tobacco and illicit drug use before and during pregnancy in Belgium between 2022-2024
41. Pregnancy and infant outcomes following prenatal exposure to brivaracetam: a multinational case series from Belgium, the Netherlands and UK
42. Pregnancy outcome following exposure to vaginal fenticonazol in pregnancy: a case report
43. Feasibility of the long term data collection on infant development in the BELpREG registry in Belgium
44. Prevalence and type of paternal medication used in the preconception period in Belgium
45. Prevalence and type of potential teratogenic medications prescribed to hospitalized pregnant women in Belgium
46. Medication adherence during and after pregnancy among women at risk for gestational hypertensive disorders
47. Physicians’ perceptions toward drug administration in pregnancy and package inserts: A qualitative study
48. Safety of azathioprine and methylprednisolone during breastfeeding: A Case Report
49. Safety of liragulitid during pregnancy: A Case Report
50. The use of azathioprine and mercaptopurine during pregnancy is associated with an increased risk of intrahepatic cholestasis of pregnancy
51. Pregnancy and infant outcomes following the use of asthma medicines with an unknown risk classification
52. Do women experience an increase in milk supply after use of over-the-counter and prescribed galactagogues?
53. Increased risk of mood disorders associated with metoclopramide treatment for nausea and vomiting during pregnancy
54. Treatment of Meniere's disease with betahistine in the first trimester of pregnancy
55. Perinatal Mental Health Issues in Breastfeeding Consultations: Insights from the Japan Drug Information Institute in Pregnancy (J-TIS)
56. Pseudoephedrine use during Pregnancy and the risk for Major congenital malformations: A Large Population-Based Cohort Study
57. The effect of combined contraceptives during breastfeeding on lactation, mothers, and infants- network meta-analysis
58. Is the use of mesalazine during pregnancy at concern for the fetal kidneys?
59. Agomelatine exposure during pregnancy: An Australian Observational Cohort Study
60. Assessing Large Language Models in Clinical Teratology: Preliminary Findings from a Multi-Model Performance Analysis
61. Register data on neonatal symptoms added to the Swedish knowledge base Janusmed Drugs and Birth Defects
62. Pregnancy-related Adverse Drug Reactions with JAK inhibitors: A Pharmacovigilance Disproportionality Analysis using VigiBase
63. Medication use in pregnant women with Polycystic Ovary Syndrome (PCOS): A nationwide cohort study from The Netherlands
64. The MediMama app – the successful implementation of a Dutch mobile app on the safety of over-the-counter medicines during pregnancy and breastfeeding
65. Safety of aripiprazole in first trimester pregnancy: a prospective cohort study
66. CGRP monoclonal antibodies for migraine and the risk of adverse pregnancy outcomes: Women’s Headache Health - a nationwide registry-based cohort study from 2018 to 2022
